Evidence map›Paper›PMID 32036477›Full record

ReviewCurrent cardiology reports2020

Diversity of Organism-Wide and Organ-Specific Endothelial Cells.

Andrew Przysinda, Wei Feng, Guang Li

Open access · greenAbstract readReview
In one paragraph

Review in Current cardiology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. IL-6 induces mitochondrial ROS production and blunts NO bioavailability in human aortic endothelial cells.American journal of physiology. Regulatory, integrative and comparative physiology · 2025
    Article
  4. The endothelium at the interface between tissues andClinical microbiology reviews · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. The vascular endothelium as decision maker in lung injury.Frontiers in cell and developmental biology · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Mechanosensing by Vascular Endothelium.Annual review of physiology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. The role of PLVAP in endothelial cells.Cell and tissue research · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrew PrzysindaDepartment of Developmental Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15201, USA.
Wei FengDepartment of Developmental Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15201, USA.
Guang LiDepartment of Developmental Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15201, USA. guangli@pitt.edu.
University of Pittsburgh · US

Funding

Cellular and Molecular Mechanisms of Atrial Cardiomyocyte Lineage Commitment R00HL133472 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LI, GUANG · 2019 to 2021
$750k
NHLBI NIH HHS R00 HL133472
6 · The paper itself

Abstract

purpose of reviewEndothelial cells are of great importance in many types of diseases including the coronary artery diseases in heart and stroke in brain. In this review, we explore the heterogeneity among endothelial cells from an organism-wide, organ-specific, and healthy versus disease perspective. RECENT

findingsRecent studies addressing the cellular heterogeneity between arterial versus venous endothelial cells (ECs) have revealed that arterial ECs have tighter junctions, a decreased immune response, anticoagulant properties while veins have both anticoagulant and procoagulant properties. Blood and lymphatic ECs are quite distinct from each other as well, with the lymphatic ECs being more involved in the immune response and lymphangiogenesis while blood vessel ECs being involved in angiogenesis and maintenance of perfusion throughout the body. ECs from various organs such as the heart, the lung, and especially the brain are quite heterogeneous and provide barriers that prevent small particles to pass through the endothelium when compared with the endothelium of the liver and the kidney that are quite porous. The heart ECs have higher angiogenesis and metabolic rates (oxidation and glycolysis) than lung, liver, and kidney ECs. Ex vivo liver and kidney ECs grow at a moderate pace, while the lung and brain ECs grow very slowly. ECs from within a tumor have fenestrae and large intracellular gaps and junctions leading to increased permeability and tumor cell overgrowth. There is a large degree of heterogeneity among organism-wide and organ-specific ECs as well as between healthy and disease-specific ECs. We believe this review will help highlight the EC heterogeneity and further advance our ability to treat cardiovascular disease and other conditions.

Indexed as

Endothelial CellsEndothelium, VascularHeartBrainHumansBlood vesselEndothelial cellsHeterogeneityLymphaticOrganism-wideOrgan-specific

Identifiers

PMID32036477
PMCPMC7894984
OpenAlexW3005294786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.